Literature DB >> 20812404

Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma.

Clive J Kelty1, Catherine W Kennedy, Gregory L Falk.   

Abstract

INTRODUCTION: The role of the number of metastatic nodes in esophageal cancer surgery is of interest. We assess predictors of survival after oesophagectomy for esophageal and gastroesophageal junction malignancy.
METHODS: Prospective data of consecutive patients undergoing oesophagectomy and systematic lymphadenectomy between 1991 and 2007.
RESULTS: Of 224 patients, 148 patients (66%) had adenocarcinoma, 70 (31%) squamous cell carcinoma, and 6 (2.6%) were other tumor types. Five-year survival was 43% with hospital mortality of 3.5%. Locoregional recurrence occurred in 14%. The total number of affected nodes significantly reduced survival (four or more metastatic nodes). Further analysis of the ratio of nodes affected to the total number resected showed a significant decrease in survival as the percentage of positive nodes increased (p < 0.001).
CONCLUSIONS: Patients undergoing surgery for esophageal cancer should be staged according to a minimum total number of metastatic lymph nodes and ratios because this more accurately predicts survival than current staging systems.

Entities:  

Mesh:

Year:  2010        PMID: 20812404     DOI: 10.1097/jto.0b013e3181e8f6b1

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  24 in total

1.  Recurrence risk model for esophageal cancer after radical surgery.

Authors:  Jincheng Lu; Hua Tao; Dan Song; Cheng Chen
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

2.  Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.

Authors:  Wan-Qin Zeng; Wen Feng; Li Xie; Chen-Chen Zhang; Wen Yu; Xu-Wei Cai; Xiao-Long Fu
Journal:  Lung       Date:  2019-11-08       Impact factor: 2.584

3.  Comparative Quantitative Lymph Node Assessment in Localized Esophageal Cancer Patients After R0 Resection With and Without Neoadjuvant Chemoradiation Therapy.

Authors:  Danica N Giugliano; Adam C Berger; Michael J Pucci; Ernest L Rosato; Nathaniel R Evans; Hanna Meidl; Casey Lamb; Daniel Levine; Francesco Palazzo
Journal:  J Gastrointest Surg       Date:  2017-06-29       Impact factor: 3.452

4.  Prognostic significance of lymph node characteristics on survival in esophageal squamous cell carcinomas.

Authors:  Ning Wu; Zhiming Chen; Liewen Pang; Qinyun Ma; Gang Chen
Journal:  Wien Klin Wochenschr       Date:  2013-01-05       Impact factor: 1.704

5.  Lymph node ratio-based staging system for esophageal squamous cell carcinoma.

Authors:  Shao-Bin Chen; Hong-Rui Weng; Geng Wang; Xiao-Fang Zou; Di-Tian Liu; Yu-Ping Chen; Hao Zhang
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

6.  The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.

Authors:  Norio Yukawa; Toru Aoyama; Hiroshi Tamagawa; Ayako Tamagawa; Yosuke Atsumi; Shinnosuke Kawahara; Yukio Maezawa; Kazuki Kano; Masaaki Murakawa; Keisuke Kazama; Masakatsu Numata; Takashi Oshima; Munetaka Masuda; Yasushi Rino
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

Review 7.  Current developments in the management of locally advanced esophageal cancer.

Authors:  Michael J McNamara; David J Adelstein
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

8.  Prognostic significance of lymph node ratio in esophageal cancer.

Authors:  Nana Wang; Yibin Jia; Jianbo Wang; Xintong Wang; Cihang Bao; Qingxu Song; Bingxu Tan; Yufeng Cheng
Journal:  Tumour Biol       Date:  2014-11-21

9.  Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy.

Authors:  Joyce Wong; Jill Weber; Khaldoun Almhanna; Sarah Hoffe; Ravi Shridhar; Richard Karl; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-07-02       Impact factor: 3.452

10.  Multidrug resistance in primary tumors and metastases in patients with esophageal squamous cell carcinoma.

Authors:  Fang Qiang; Ren Guangguo; Han Yongtao; Dong Dandan; Yang Hong
Journal:  Pathol Oncol Res       Date:  2013-03-19       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.